Document Detail


Management of carpal tunnel syndrome.
MedLine Citation:
PMID:  19654417     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Estimates suggest that around 1 in 10 people develop carpal tunnel syndrome at some point. The condition comprises potentially disabling sensory and/or motor symptoms in the hand, caused by compression of the median nerve, and carries considerable implications for employment and healthcare costs. Current standard treatment options are splinting, local corticosteroid injections and surgery, and there are a range of other suggested treatments. Here we review how best to manage patients with carpal tunnel syndrome.
Authors:
-
Related Documents :
18771827 - Intraoral approach for surgical treatment of eagle syndrome.
7373407 - Tapia's syndrome caused by a neurofibroma of the hypoglossal and vagus nerves: case rep...
20081627 - The carpal tunnel.
15237127 - A new clinical test for radial tunnel syndrome--the rule-of-nine test: a cadaveric study.
8495097 - Successful trimethoprim-sulfamethoxazole therapy in a patient with hyperimmunoglobulin ...
20686427 - Imbalance of plasminogen activator inhibitor type-1 (pai-1) and tissue plasminogen acti...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug and therapeutics bulletin     Volume:  47     ISSN:  0012-6543     ISO Abbreviation:  Drug Ther Bull     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-05     Completed Date:  2009-10-01     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0112037     Medline TA:  Drug Ther Bull     Country:  England    
Other Details:
Languages:  eng     Pagination:  86-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / administration & dosage
Carpal Tunnel Syndrome / diagnosis,  etiology,  therapy*
Humans
Injections, Intralesional
Neural Conduction / physiology
Physical Examination / methods
Referral and Consultation
Risk Factors
Splints
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo.
Next Document:  So, what exactly is a cytokine?